Article Versions Notes

Allam AA, Eleraky NE, Diab NH, Elsabahy M, Mohamed SA, Abdel-Ghaffar HS, Hassan NA, Shouman SA, Omran MM, Hassan SB, et al. Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations. Pharmaceutics. 2022; 14(2):220. https://doi.org/10.3390/pharmaceutics14020220

Allam, Ayat A., Nermin E. Eleraky, Nadeen H. Diab, Mahmoud Elsabahy, Sahar A. Mohamed, Hala S. Abdel-Ghaffar, Nivin A. Hassan, Samia A. Shouman, Mervat M. Omran, Sahar B. Hassan, and et al. 2022. "Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations" Pharmaceutics 14, no. 2: 220. https://doi.org/10.3390/pharmaceutics14020220

Allam, A. A., Eleraky, N. E., Diab, N. H., Elsabahy, M., Mohamed, S. A., Abdel-Ghaffar, H. S., Hassan, N. A., Shouman, S. A., Omran, M. M., Hassan, S. B., & Eissa, N. G. (2022). Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations. Pharmaceutics, 14(2), 220. https://doi.org/10.3390/pharmaceutics14020220